February 1, 2024 · Form 4 insider transaction
RYAN ARTHUR F sold 8 shares of Regeneron Pharmaceuticals, Inc. at $959.68 per share, a transaction worth $7.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.; Represents volume-weighted average price of sales of 8 shares of Company stock on February 1, 2024 at prices ranging from $959.14 to $959.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.